Fludeoxyglucose (18F) Injection; Cracket vial
Fludeoxyglucose (18F) vial containing 24.80 mL (30.23 GBq of the product) used to administered the d...
Publisher
Canada
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Health Canada Recalls and Safety Alerts
- Region
- Canada
- Scope
- Regulatory
- Published
- July 2, 2026
- Language
- EN
Topics
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Fludeoxyglucose (18F) vial containing 24.80 mL (30.23 GBq of the product) used to administered the d...
Source route
Continue on recalls-rappels.canada.ca
Leave the platform to read the original full article on the publisher site.
Source: Health Canada Recalls and Safety Alerts
Scope: Regulatory
Related coverage
More related coverage
NHS injury costs recovery scheme: April 2026 to March 2027
Data on the funds collected by the Compensation Recovery Unit and funds paid to the NHS.
Work-related quality of life of the adult social care workforce in England in 2025
Survey results from the second wave of the Adult Social Care Workforce Survey, undertaken between Au...
Ebola and Marburg haemorrhagic fevers: outbreaks and case locations
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF)...
Outbreaks under monitoring in 2026
Latest information on global disease events under monitoring.